Trulieve Cannabis Corp. is trading at $9.74 (13.12% up) after announcing a major corporate restructuring to pursue a listing on the New York Stock Exchange (NYSE).
- The company announced on June 3, 2026, that it has entered into agreements to deconsolidate its subsidiary, Harvest Enterprises, to segregate its mixed-use cannabis business from its medical operations.
- This strategic move, which includes the sale of a 10% voting stake in the restructured Harvest for approximately $14.8 million, is designed to align the company's structure with U.S. exchange listing requirements.